Black Diamond Therapeutics, Inc. (BDTX)

BDTX Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	36.44	56.22	34.32	65.8	34.61
Short-Term Investments	62.14	75.18	88.49	143.99	280.46
Cash & Short-Term Investments	98.58	131.4	122.81	209.79	315.07
Cash Growth	-24.98%	7.00%	-41.46%	-33.41%	103.71%
Prepaid Expenses	2.6	2.63	4.9	5.92	4.49
Total Current Assets	101.18	134.03	127.71	215.7	319.55
Property, Plant & Equipment	20.4	23.71	27.38	30.74	8.79
Other Long-Term Assets	1.07	0.82	1.17	1.24	1.33
Total Assets	122.64	158.57	156.26	247.68	329.67
Accounts Payable	4.01	2.32	1.88	4.11	2.54
Accrued Expenses	13.16	14.21	10.54	19.22	10.63
Current Portion of Leases	3.4	3.11	2.84	0.32	1.05
Total Current Liabilities	20.57	19.65	15.26	23.64	14.22
Long-Term Leases	18.78	22.19	25.3	28.14	7.69
Total Liabilities	39.36	41.83	40.56	51.78	21.91
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	570.36	534.19	452.5	440.13	425.36
Retained Earnings	-487.11	-417.43	-334.99	-243.82	-118.22
Comprehensive Income & Other	0.02	-0.03	-1.82	-0.41	0.61
Total Common Equity	83.29	116.74	115.7	195.9	307.76
Shareholders' Equity	83.29	116.74	115.7	195.9	307.76
Total Liabilities & Equity	122.64	158.57	156.26	247.68	329.67
Total Debt	22.19	25.3	28.14	28.46	8.74
Net Cash (Debt)	76.39	106.1	94.67	181.33	306.33
Net Cash Growth	-28.00%	12.08%	-47.79%	-40.81%	98.06%
Net Cash Per Share	1.39	2.41	2.61	5.01	9.31
Filing Date Shares Outstanding	56.66	51.72	36.48	36.27	36.14
Total Common Shares Outstanding	56.64	51.65	36.43	36.23	36.08
Working Capital	80.6	114.39	112.45	192.06	305.34
Book Value Per Share	1.47	2.26	3.18	5.41	8.53
Tangible Book Value	83.29	116.74	115.7	195.9	307.76
Tangible Book Value Per Share	1.47	2.26	3.18	5.41	8.53
Machinery	0.02	0.02	0.83	0.82	0.34
Construction In Progress	-	-	-	0.15	0.15
Leasehold Improvements	2.51	2.51	2.51	2.44	0.07

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q